Physician profile
Ashley Baker
NPI 1447906755
$835.18
in general payments reported to CMS, 2019-2025
9 companies · $20.31 in 2025
The $20.31 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $314 · 2023: $171 · 2024: $329 · 2025: $20.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $521.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $278.02 | 2022-2024 | Uzedy, Austedo, Austedo Xr |
| Abbvie INC. | $245.35 | 2022-2024 | |
| Idorsia Pharmaceuticals US INC | $133.74 | 2022-2023 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $62.84 | 2023-2024 | Rexulti, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $35.60 | 2024-2025 | Caplyta |
| Avanir Pharmaceuticals, INC. | $30.44 | 2022 | |
| Axsome Therapeutics, INC. | $19.72 | 2024 | Auvelity |
| Inari Medical, INC. | $15.36 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.